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Human pluripotent stem cells offer promise for use in
cell-based therapies for brain injury and diseases.
However, their cellular behavior is poorly understood.
Here we show that the expression of the brain-
specific microRNA-9 (miR-9) is turned on in human
neural progenitor cells (hNPCs) derived from human
embryonic stem cells. Loss of miR-9 suppressed
proliferation but promoted migration of hNPCs
cultured in vitro. hNPCs without miR-9 activity also
showed enhanced migration when transplanted into
mouse embryonic brains or adult brains of a mouse
model of stroke. These effectswere not due to preco-
cious differentiation of hNPCs. One of the key targets
directly regulated by miR-9 encodes stathmin, which
increases microtubule instability and whose expres-
sion in hNPCs correlates inversely with that of miR-9.
Partial inhibition of stathmin activity suppressed the
effects of miR-9 loss on proliferation and migration
of human or embryonic rat neural progenitors. These
results identifymiR-9 as a novel regulator that coordi-
nates the proliferation and migration of hNPCs.
INTRODUCTION
The controlled differentiation of human embryonic stem cells
(hESCs) (Hochedlinger and Jaenisch, 2003; Yu and Thomson,
2008), adult (Zhao et al., 2008; Duan et al., 2008), or induced
pluripotent stem cells (iPSCs) (Yamanaka, 2007; Yu and Thom-
son, 2008) into neural progenitor cells (NPCs) opens fascinating
prospects for cell replacement in injured or diseased brains or
spinal cords. The clinical efficacy of grafted progenitor cells
critically depends on their ability to migrate to the appropriate
sites in the adult central nervous systemwithout unwanted prolif-
eration and tumor formation. However, little is known about the
cellular behavior of hNPCs derived from hESCs or how theirproliferation and migration are coordinated. Although experi-
ments in rodent models have provided important molecular
insights into these cellular processes (e.g., Cobos et al., 2007;
Mao et al., 2009), studies performed directly on human cells
are of great importance for developing effective therapeutic
approaches.
MicroRNAs (miRNAs) are a class of small, noncoding RNAs of
21–23 nucleotides that regulate gene expression at the post-
transcriptional level (Ambros, 2001; Hobert, 2008). They mostly
destabilize target mRNAs or suppress their translation by
binding to complementary sequences in the 30 untranslated
region (30UTR) (Filipowicz et al., 2008). However, miRNAs also
target 50UTRs or coding regions and, in a few cases, upregulate
expression of their target mRNAs (Tay et al., 2008; Vasudevan
et al., 2007). Many miRNAs are developmentally regulated and
expressed in tissue-specific patterns, indicating important
functions in development (Bushati and Cohen, 2007; Zhao and
Srivastava, 2007). Despite rapid progress in understanding their
functions, the precise roles of many miRNAs in the proliferation,
migration, and differentiation of hESCs and hESC-derived
hNPCs remain unknown.
Several miRNAs have been implicated in neuronal develop-
ment in model organisms (Kosik, 2006; Gao, 2008). One, miR-9,
is 100% conserved at the nucleotide sequence level from flies
to humans, but its expression patterns and developmental
functions are not conserved across species. In Drosophila,
miR-9a is expressed in epidermal cells in developing embryos
and in wing discs, where it ensures the precise specification of
sensory organ precursors (SOPs) by downregulating Senseless
in non-SOP cells and also affects wing development through
dLMO (Li et al., 2006; Biryukova et al., 2009). In zebrafish, miR-9
is expressed in the developing brain (e.g., in regions adjacent to
the midbrain-hindbrain boundary) and promotes neurogenesis
by suppressing Her5 and Her9 (Leucht et al., 2008). In rodents,
miR-9 is specifically expressed in the brain and is abundant in
neurogenic regions in embryos and adults (Deo et al., 2006). It
has been implicated in embryonic Cajal-Retzius cell differentia-
tion (Shibata et al., 2008), regulation of BK channel mRNA splice
variants in response to alcohol (Pietrzykowski et al., 2008),
and adult neural progenitor differentiation (Zhao et al., 2009).Cell Stem Cell 6, 323–335, April 2, 2010 ª2010 Elsevier Inc. 323
Figure 1. miR-9 Expression during Neural Differentiation of hESCs
(A) Phase-contrast images of cells at different stages of neural differentiation of hESCs. hESCs (H9 line) were maintained in the presence of FGF2 on mouse
embryonic fibroblast (MEF) feeder cells. DIV 0 is the day hESCs were dissociated fromMEFs. Initial differentiation was induced by the formation of EBs, followed
by neural induction in the presence of FGF2 and N2 supplements. Rosette-forming colonies of neuroectodermal cells appeared at 13–16 DIV. Neural progenitors
in rosettes were dissociated and expanded in suspension cultures at 16–46DIV to form neurospheres. Dissociated neural progenitors were exposed to BDNF and
GDNF to differentiate into neurons at 43–60 DIV.
(B) Expression profiles of cellular markers monitored by qRT-PCR at different stages of neural differentiation. Values on x axis are DIV after culturing hESCs in
suspension. Expression was normalized to GAPDH levels, and the highest level for a given marker was always taken as 100. Values are mean ± SEM from at least
three independent cultures. NANOG and OCT4 are markers of pluripotent ESCs. SOX2 and PAX6 are expressed in neural progenitors, andMAP2 is a marker of
mature neurons.
(C) Expression profiles of miR-367, an miRNA highly enriched in stem cells; miR-124, an miRNA highly enriched in postmitotic neurons; and miR-9, miR-9*, and
pre-miR-9-2, which gives rise to miR-9 and miR-9* during neural differentiation of hESCs. Values are mean ± SEM.
(D–M) In situ analysis of miR-9 expression during hESC neural differentiation.
(D–F) miR-9 is not expressed in SOX2-positive rosette structures as shown by the lack of miR-9 in situ labeling in SOX2-immunopositive cells.
(G) miR-9 is strongly expressed in neurospheres as indicated by the green signal of in situ labeling.
(H–J) Scrambled control probe was used as a negative control to show the background in situ labeling in SOX2-positive cells in rosette structures.
(K) Scrambled control probe did not label hNPCs in neurospheres.
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MicroRNA-9 in Human Neural ProgenitorsHowever, the exact functions of miR-9 in hNPCs are unknown.
The mRNA targets of a specific miRNA can shift rapidly through
evolution, and there are many more miRNAs in humans than
in rodents (Ambros and Chen, 2007; Bartel, 2009). Moreover,
miRNAs are potential molecular targets of therapeutic ap-
proaches. Thus, it is vital to understand the unique functions
and targets of each miRNA in human cells.
Here we demonstrate a novel essential role for miR-9 in
coordinating the proliferation and migration of hESC-derived
hNPCs at their early stage of maturation. We also identify the
mRNA encoding stathmin, a protein that increases microtubule
instability, as a novel key target of miR-9 to mediate its effects
in these biological processes. Moreover, hNPCs without miR-9
showed enhanced migration when transplanted into the embry-
onic mouse brain or the adult brain of a mouse model of stroke.
These studies identify a novel function for miR-9 in hNPCs.
RESULTS
Neuronal Differentiation of hESCs
To differentiate H9 hESCs into postmitotic neurons, we com-
bined two protocols (Li and Zhang, 2006; Zhang et al., 2001)
with some modifications. This differentiation process includes
neural induction, expansion of homogenous populations of
hNPCs, and neuronal maturation (Figure 1A). Initial multilineage
differentiation was induced by forming embryoid bodies (EBs),
followed by neural induction and rosette formation in the pres-
ence of basic fibroblast growth factor 2 (FGF2) and serum-free
N2 supplement for 12 days as described (Zhang et al., 2001).
The appearance of elongated cells radially arranged in rosettes
is the hallmark of neuroepithelial cells in the neural tube (Elkabetz
et al., 2008). Rosette cells were isolated and expanded in
suspension cultures for about 1 month to allow neurospheres
to enlarge. After exposure to brain-derived neurotrophic factor
(BDNF) and glial cell line-derived neurotrophic factor (GDNF),
dissociated hNPCs from neurospheres differentiated into mostly
postmitotic neurons that are immunopositive for the neuronal
marker TUJ1 (Figure S1A available online).
In vitro neuronal differentiation of hESCs was monitored from
the day cells were placed in suspension culture (0 DIV) to 60 DIV
by immunocytochemistry and extensive mRNA expression
profiling for neural markers. Relative gene expression analysis
by quantitative RT-PCR (qRT-PCR) showed rapid loss of the
pluripotent ESC markers NANOG and OCT4 (Figure 1B). The
peak expression of the neural markers SOX2 and PAX6 (Fig-
ure 1B) upon rosette formation at 16 DIV indicated targeted
differentiation to neural lineages, which was further confirmed
by immunostaining for nestin and SOX2 (Figures S1C and S1D).
Mechanically isolated rosette cells were then propagated in
suspension culture to form neurospheres consisting of hNPCs.
At this stage, most if not all the cells in neurospheres were
immunopositive for nestin and SOX2 (Figures S1E and S1F),
and only a few cells expressed neuronal markers such as TUJ1
(Figure S1G). Terminal differentiation of the expanded progeni-
tors (30–45 DIV) over 2 more weeks yielded a cell population(L) miR-9 (as indicated in green) was expressed in MAP-2-positive human neuro
(M) miR-9 (as indicated in green) is also expressed at a low level in S100b-positi
Scale bars represent 100 mm. See also Figure S1.(45–60 DIV) that contained more than 70% TUJ1-positive post-
mitotic neurons (Figure S1A). Accordingly, qRT-PCR showed
a marked increase in the expression level of the neuronal marker
MAP2 and no expression of the stem/progenitor cell markers
SOX2 and PAX6 in terminally differentiated cells (Figure 1B).
We also examined molecular markers (Elkabetz et al., 2008)
that indicate different stages of maturation for hNPCs (Figures
S1K–S1N). These analyses confirmed the differentiation of
hESCs into hNPCs and postmitotic neurons.
miR-9 Expression Starts at the Early Neurosphere Stage
Next we examined the expression of several miRNAs during
neuronal differentiation of hESCs. miR-367, a marker of pluripo-
tent ESCs (Suh et al., 2004), was highly expressed in hESCs and
EBs, but its expression decreased significantly at later stages
(Figure 1C). In contrast, miR-124, a miRNA found at high levels
in postmitotic neurons (Lagos-Quintana et al., 2002), was highly
expressed in terminally differentiated human neuronal cultures
(Figure 1C).
miR-9 expression was turned on at 16–20 DIV during neuro-
sphere formation and increased in hNPCs before terminal differ-
entiation (Figure 1C). In situ hybridization confirmed that miR-9
was not expressed in rosette cells but was highly expressed in
neurospheres (Figures 1D–1G). A scrambled probe (negative
control) showed mere background staining at both stages
(Figures 1H–1K). miR-9 was also expressed in MAP2-positive
postmitotic human neurons (Figure 1L) and, at lower levels, in
human astrocytes (Figure 1M).
Expression of miR-9*, which is processed from the opposite
strand of the miR-9 precursor (pre-miR-9), mirrored that of
miR-9 (Figure 1C). Pre-miR-9 is expressed from three chromo-
somes in humans and rodents. Pre-miR-9-2 expression from
chromosome 5 correlated with miR-9 expression at different
stages of neural differentiation of hESCs (Figure 1C), while pre-
miR-9-1 and pre-miR-9-3 were undetectable in hESC-derived
hNPCs (data not shown), suggesting little or no expression.
miR-9 Promotes Early hNPC Proliferation
hNPCs undergo extensive proliferation during the early neuro-
sphere stage. The temporally regulated expression of miR-9
in hNPCs at this stage raises the possibility that miR-9 may
regulate expansion of the NPC pool. Studying loss-of-function
phenotypes is a powerful way to elucidate the normal functions
of endogenous miRNAs in particular developmental processes.
To this end, we used a locked nucleic acid (LNA) antisense
probe to knock down miR-9 activity in the early stage of hNPC
maturation, when miR-9 just starts to be expressed. Because
this probe shares considerable sequence similarity with miR-9*,
we sought to ensure that the probe did not affect the interaction
of miR-9* and its targets. We cotransfected HEK293 cells with
anti-miR-9 and pre-miR-9-2 with artificial reporter constructs
containing miR-9 or miR-9* binding sites in the 30UTR. The
anti-miR-9 LNA probe specifically inhibited miR-9 function but
did not interfere with the interaction of miR-9* with its targets
(Figure S2A).ns (as indicated by red).
ve astrocytes (as indicated by red).
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Figure 2. miR-9 Is Required to Promote Proliferation of Early Neural Progenitors
(A and B) The LNA-anti-miR-9 probe complementary to miR-9 was introduced at 16 DIV in dissociated human NPCs dissected from rosettes and cultured
in suspension. Relative levels of mature miR-9 (A) and miR-9* (B) were measured by qRT-PCR 24, 48, and 96 hr after transfection with anti-miR-9 or control
scrambled probe. Values are mean ± SEM.
(C) Phase-contrast images of hESC-derived neurospheres transfected with scrambled or anti-miR-9 probe. Scale bars represent 100 mm.
(D) Neurosphere diameters 5 days after transfection. Numbers on x axis indicate the number of neurospheres measured. Values are mean ± SEM.
(E) TUNEL staining indicates that loss of miR-9 does not affect the survival of human neural progenitors. Quantification and representative images of TUNEL
staining are presented.
(F) miR-9 knockdown does not have a cytotoxic effect on hNPCs. hESC-derived neural progenitors were mock transfected or transfected with a scrambled
LNA probe or with anti-miR-9 LNA probe at 16 DIV. Medium was changed 20 hr before LDH assays for cytotoxicity 48 hr and 96 hr after transfection. n.s.,
not significant. Values are mean ± SEM.
(G) BrdU incorporation was decreased in hNPCs and rat NPCswhenmiR-9 was knocked down. The percentage of BrdU-positive cells at 3 days after transfection
is shown. Values are mean ± SEM. **p < 0.01 (n = 3).
(H) hNPCswere transfected with the LNA-anti-miR-9 or scrambled probe at 16 DIV of neuronal differentiation. Neurospheres were collected 24 hr later and split in
96-well plates. Metabolic activity was measured (Abs. 450 nm) via WST-1 proliferation assay at this time point and every day. The average absorbance for each
time point was normalized to the value on day 1 after transfection. Values are mean ± SEM of 8 to 16 wells per time point and per conditions. *p < 0.05.
See also Figure S2.
Cell Stem Cell
MicroRNA-9 in Human Neural ProgenitorsTransfecting a high percentage of hNPCs in neurospheres is
difficult. The best time for efficient transfection of dissociated
neurospheresand to characterize targets ofmiR-9 in early hNPCs
is the transition from rosettes to neurospheres at 16 DIV, shortly
before miR-9 expression begins. Rosettes were extracted from
surrounding cells with dispase at 16 DIV, mechanically dissoci-
ated into10- to50-cell aggregates, anddivided into threesuspen-
sion cultures for transfection. At 24 hr after transfection with the
anti-miR-9 LNAprobe, the level ofmaturemiR-9 in hESC-derived
neurospheres was markedly reduced and remained at that low
level up to 96 hr after transfection (Figure 2A). Even 6 days after
anti-miR-9 LNA transfection, the level of miR-9 remained low
(30%–40%). Thus, all the experiments presented in this study
examine the functions of endogenous miR-9 in newly formed
hNPCs. Anti-miR-9 did not affect miR-9* expression in hNPCs
(Figure 2B), indicating the specificity of the knockdown.
Neurospheres transfected with anti-miR-9 were morphologi-
cally similar to controls. Interestingly, loss of miR-9 activity326 Cell Stem Cell 6, 323–335, April 2, 2010 ª2010 Elsevier Inc.reduced the size of neurospheres 5 days after the knockdown
(Figure 2C); at 120 hr, the mean diameter was 145 ± 7 (n = 163)
versus 193 ± 11 mm in controls (n = 134) (p < 0.001) (Figure 2D).
To confirm this finding in another established system of neural
progenitor differentiation, we used rat primary cortical progenitor
cells from E14.5 Sprague-Dawley rats (R&D Systems). miR-9
was expressed in embryonic rat cortical NPCs and differentiating
neurons and, to a lesser extent, primary astrocytes, as shown by
qRT-PCR (Figure S2B). In contrast, miR-124 was highly ex-
pressed in postmitotic neurons derived from rat cortical NPCs
(Figure S2C). Thus, rodent miR-9 expression in a rat primary
culture system seems to mimic human miR-9 expression in
hNPCs and their progeny. Loss of miR-9 also decreased the
size of rat neurospheres (data not shown), as in hNPCs.
TUNEL analysis, performed to examine cell death, revealed
that loss of miR-9 activity did not affect the survival of hNPCs
in newly formed neurospheres (Figure 2E). We confirmed this
result in embryonic rat NPCs (Figure S2D). Furthermore, a lactate
Figure 3. Loss of miR-9 Function Delays Early Neural Progenitor Maturation
(A–I) miR-9 knockdown does not lead to precocious differentiation of rat embryonic NPCs as shown by immunostaining.
(A) Proportions of cells expressing the given marker among all human cells at the neurosphere stage visualized by nuclear staining. No difference is observed
between the scrambled and anti-miR-9 transfected cells 7 days after transfection of hNPCs. Values are mean ± SEM.
(B–I) Expression of the neural progenitor marker nestin (B, D) and the neuronal marker TUJ1 (F, H) in control or anti-miR-9-transfected hNPCs. (C), (E), (G), and (I)
show nuclear staining in blue.
(J) qRT-PCR analysis of the expression levels of molecular markers for neural progenitors. Three days after transfection with scrambled or anti-miR-9 LNA probe,
total RNAs were extracted from cells in the newly formed neurospheres and analyzed by qRT-PCR. Markers analyzed include those common to neural stem cells
(PAX6, SOX2), specific to the early state of neural progenitors (PLAGL1, DACH1, PLZF), expressed in neuroblasts (TUJ1, DCX, NEUROD1, MAP1B), specific for
the anterior (OTX2, EMX2, FOXG1) or the posterior (GBX2, HOXB4, EGR2) identity, oligodendrocyte precursor marker (CSPG4), and neurogenic factor (MEF2C).
Three days after transfection of anti-miR-9 LNA probe, the levels of PAX6 and SOX2 were increased, while the level of MEF2Cwas decreased, indicating delayed
maturation. However, no switch toward an anteroposterior identity was observed, and the neuroblast markers were not affected by loss of miR-9 function.
Indeed, the expression levels of early NPCs markers did not change when miR-9 is inhibited. Thus, loss of miR-9 activity did not cause premature differentiation
of neural progenitors. In fact, it suggests that the loss of function delayed progression of hNPCs to a more mature neuronal progenitor fate. Values are
mean ± SEM. *p < 0.05.
See also Figure S3.
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transfection of hNPCs with anti-miR-9 LNA probes (Figure 2F).
Thus, miR-9 does not affect cell survival of NPCs, and the
decreased size of human neurospheres after miR-9 knockdown
probably does not result from increased apoptotic cell death.
To assess the proliferation rates of NPCswith or withoutmiR-9
activity, we performed BrdU labeling experiments on hNPCs and
rat cortical NPCs. Cell proliferation was markedly decreased
when miR-9 activity was lost (Figure 2G). Cell counting analysis
of dissociated embryonic rat cortical NPCs (monolayer culture)
at different times after anti-miR-9 transfection showed slower
proliferation in the absence of miR-9 (Figure S2E). To further
confirm this finding, we used WST-1 cell proliferation reagent
(Roche Applied Science), a water-soluble tetrazolium salt whose
rate of cleavage by mitochondrial dehydrogenases correlateswith the number of viable cells in culture. Knockdown of miR-9
slowed the proliferation of hNPCs (Figure 2H) and of rat cortical
NPCs in monolayer culture or in suspension (Figures S2F and
S2G). These findings strongly indicate that miR-9 is required to
promote the proliferation of early human and embryonic rat
NPCs.
To exclude the possibility that loss of miR-9 resulted in preco-
cious differentiation of hNPCs, we performed the following
experiments. Immunostaining of dissociated human neuro-
spheres showed no effect of loss of miR-9 activity on neuronal
differentiation. The cells kept their neural progenitor properties,
as shown by expression of the progenitor marker nestin at 7
days after transfection of hNPCs (Figures 3A and 3D). Again,
we used rat cortical NPCs and confirmed that loss of miR-9
activity did not lead to precocious differentiation of rat NPCsCell Stem Cell 6, 323–335, April 2, 2010 ª2010 Elsevier Inc. 327
Figure 4. miR-9 Limits Migration of Rat NPCs and hNPCs In Vitro
(A–D) miR-9 knockdown caused rat NPCs to migrate away from neurospheres on plastic substrate. The cells were cultured for 72 hr and 144 hr after transfection
with scrambled control (A, B) or anti-miR-9 (C, D).
(E) Distance from the edge of the neurospheres to the most distant nucleus of the migrating cells. Values are mean ± SEM.
(F) Number of migrating cells with or without miR-9 activity. Values are mean ± SEM.
In (E) and (F), the number of neurospheres analyzed is indicated in each column.
(G–L) miR-9 knockdown resulted in precocious migration of hNPCs from the neurospheres cultured in the 3D matrix. hNPCs were dissociated from rosettes at
16 DIV, transfected, cultured for 3 days in suspension, and embedded in Matrigel; the time of embedding is indicated.
(M) Distance from the edge of the neurosphere to the most distant nucleus of the outmigrating cells. Values are mean ± SEM from 35 control and 45 miR-9-trans-
fected neurospheres at 24 hr and 42 control and 43 transfected neurospheres at 48 hr.
See also Figure S4.
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TUJ1-, or GFAP-positive rat cells (Figure S3). In a more detailed
analysis of the expression of different molecular markers that are
useful for following the sequential events controlling neural
progenitor maturation and specification (Elkabetz et al., 2008),
we confirmed that loss of miR-9 did not cause precocious differ-
entiation and showed that it may even slow the maturation of
hNPCs (Figure 3J). Three days after transfection of anti-miR-9
LNA probe, the levels of the neural progenitor cell markers
PAX6 and SOX2 were increased, while the neurogenic transcrip-
tion factorMEF2Cwas decreased in the absence ofmiR-9. PAX6
and SOX2 were more highly expressed in the pluripotent rosette
cells at 16 DIV than in neurospheres (Figure 1B). In contrast,
MEF2C expression mimicked miR-9 expression during neuronal
differentiation of hESCs (Figure S1N). Thus, these findings
suggest that miR-9 loss of function delays progression of hNPCs
to a more mature neural progenitor fate, indicating that reduced
proliferation in the absence of miR-9 activity is not due to their
precocious differentiation.328 Cell Stem Cell 6, 323–335, April 2, 2010 ª2010 Elsevier Inc.miR-9 Delays Early hNPC Migration In Vitro
Tight coordination of the proliferation, migration, and differentia-
tion of NPCs is essential for the proper development of the
nervous system (Ayala et al., 2007) and is equally important in
the subventricular zone of the adult brain, where miR-9 is highly
expressed (Deo et al., 2006). After knockdown of miR-9 in
embryonic rat cortical NPCs, we noticed that many cells
migrated radially out of the neurospheres, mainly in chains,
onto the plastic substrate (Figures 4C and 4D). In contrast, 3 or
6 days after transfection of rat cortical NPCs with scrambled
probe, the neurospheres remained largely intact, with many
fewer cells migrating (Figures 4A and 4B). We quantified this
migration phenotype in two ways. We measured the distance
from the neurosphere to the nucleus of the most distant cell at
various times after transfection (Figure 4E). Second, we counted
the number of cells that migrated (Figure 4F). Quantitative anal-
ysis of both parameters from a large number of neurospheres
demonstrated an essential role of miR-9 in limiting these cells
migrating away from neurospheres (Figures 4E and 4F).
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of hESC-derived hNPCs at the early neurosphere stage, when
miR-9 expression begins. Because hNPCs are difficult to culture
and their migratory behavior has not yet been described, we
tested several migration assays and culture conditions. The
three-dimensional (3D) Matrigel cell migration assay proved
most suitable (Gadea et al., 2007). Increasing evidence indicates
that cellular behavior in a 3D environment reflects more accu-
rately the in vivo situation. Neurospheres newly derived from
hESCs were embedded in Matrigel/medium gel (1:1) 3 days after
transfection with scrambled control or anti-miR-9, and cell
migration was monitored (Figures 4G–4L). Within 2.5 hr, filamen-
tous processes were seen outside neurospheres in which miR-9
activity was inhibited (Figure 4J) but not in controls (Figure 4G).
Over the first 24 hr, cells migrated from the neurospheres into
the matrix, in chains or as individual cells. Both the number of
cells that migrated and the distance from the edge of the neuro-
spheres to the nucleus of the most distant migrating cells were
significantly greater at 24 and 48 hr after embedding in Matrigel
(Figure 4M), at 4 and 5 days after transfection with anti-miR-9,
and at later times (data not shown).
To further demonstrate that the migratory phenotype did not
reflect precocious differentiation and that the cells maintained
their neural progenitor properties, we stained cells for markers
of NPCs and differentiated neurons or astrocytes 3 days after
plating on Matrigel (6 days after transfection). Almost all migra-
tory cells showed robust staining with the nestin antibody, with
very few positive for TUJ1 or GFAP (Figure S4). Thus, migratory
cells from the neurospheres at this early maturation stage main-
tained their neural progenitor properties without miR-9 activity.
Furthermore, as shown in Figure 3, loss of miR-9 function in
the early-hNPCs delayed their maturation process, which further
supports our conclusion that miR-9 promotes proliferation and
prevents excessive migration of early stage hNPCs.
miR-9 Delays Early hNPC Migration In Vivo
To examine whether loss of miR-9 activity also affects the migra-
tory behavior of hNPCs in vivo, we transfected neurospheres
newly derived from hESCs with scrambled or anti-miR-9 LNA
probes and transduced them with GFP-FUGW at 16 DIV. Two
days after transfection, individual neurospheres with similar
diameters were transplanted into the medial ganglionic emi-
nence (MGE) of brain slices from E14.5 C57Bl/6 mouse embryos
(Figure 5A). Four to five days later, many migrating cells main-
tained their progenitor identity, as shown by positive immunos-
taining for the progenitor marker nestin and negative staining
for the postmitotic neuronal marker TUJ1 (Figures S5A–S5I).
We measured the average of the five longest migrations of indi-
vidual hNPCs in each brain slice. In the absence of miR-9
activity, more hNPCs migrated out from the neurospheres
toward the neocortex and migrated 2.8-fold farther than control
neurospheres (350 ± 26 mm [n = 34] versus 124 ± 22 mm [n = 29])
(Figures 5B–5D).
Migration of NPCs is important during development of the
embryonic nervous system and also for repair after injury in the
adult brain. To explore whethermiR-9 canmodulate themigration
of transplanted hNPCs toward an injury site in the adult brain, we
transfected hNPCs at 16 DIV with anti-miR-9 or control LNA
probes. Neurospheres were dissociated 48 hr later, and hNPCs(3 3 104) were transplanted into the striatum of immunodeficient
adult mice 1 week after induction of permanent focal ischemia
(Figure 5E), as described (Zhu et al., 2008). Migration was as-
sessed 48 hr after transplantation by immunostaining with an
antibody against human mitochondria (hMit) and counting
hMit-positive cells in four areas: 0–200, 200–400, 400–600, and
>600mmaway from the transplantation site (n = 8mice per group).
Control hNPCs were mostly confined to the bolus with limited
radialmigration (Figure5F), butmorehNPCswithoutmiR-9activity
migrated toward the ischemic areas (Figures 5G and 5H). For
instance, no control hNPCswere foundbeyond400mm.However,
anti-miR-9-treated hNPCs were seen in the 400–600 mm area in
seven of eight mice transplanted and beyond 600 mm in five
(Figure 5H). The migrating hNPCsmaintained their neural progen-
itor properties. For instance, migrating hNPCs labeled with hMit
antibody did not express TUJ1 (Figures S5J–S5O).
Further analysis revealed thatmiR-9 knockdown increased the
innate migratory potency of hNPCs in vivo. Although migration
away from the ischemic area was observed (Figure S6E), more
cells migrated toward the ischemic area than in the opposite
direction, indicating a response to chemoattractants secreted
from the ischemic brain region (Figures S6C, S6D, and S6F).
These results demonstrate a cell-autonomous function for
miR-9 and enhanced in vivo migration of early hNPCs without
miR-9 activity.
miR-9 Regulates Stathmin Expression in Early hNPCs
To understand the mechanism by which miR-9 limits the migra-
tion of hESC-derived hNPCs, we searched for direct targets
of miR-9 whose expression is downregulated at the onset of
miR-9 expression. By using miRNA target prediction algorithms,
including an unpublished one that considers both complemen-
tarity and target site accessibility (Fish et al., 2008), we identified
several potential targets (Tables S1–S3). Most miRNAs decrease
the stability of target mRNAs by cleavage or deadenylation (Fili-
powicz et al., 2008). Therefore, we used qRT-PCR to profile the
expression of predicted target mRNAs at different stages of
neural differentiation of hESCs. We then selected genes whose
expression profiles negatively correlated with miR-9 expression
during the early stage of hNPCmaturation (16–20DIV) (Table S4),
including STMN1 (stathmin), CHMP2B, and SIRT1 (Figure 6A).
To demonstrate whether the predicted targets are directly
regulated by miR-9 at 16–20 DIV, we quantified mRNA expres-
sion by qRT-PCR in hNPCs 24 hr after transfection with anti-
miR-9. The mRNA and protein levels of stathmin, CHMP2B,
and SIRT1 were significantly upregulated (Figures 6B and 6C).
Moreover, overexpression of the miR-9 precursor (pre-miR-9-2)
in HEK293 cells showed that stathmin, CHMP2B, and SIRT1
mRNA levels were reciprocally regulated by miR-9 abundance.
Their expression was unchanged when the control miRNA,
miR-124, was overexpressed (Figure 6D). Thus, these mRNAs
are indeed regulated by miR-9 at the early neurosphere stage.
miR-9 regulates different targets in different model organisms
(e.g., Li et al., 2006; Leucht et al., 2008; Pietrzykowski et al.,
2008). Among its targets in hNPCs at the early neurosphere
stage, the stathmin gene is most interesting. It encodes a devel-
opmentally regulated cytosolic phosphoprotein with a catas-
trophe-promoting microtubule-depolymerization activity (Bel-
mont and Mitchison, 1996) and is prominently expressed inCell Stem Cell 6, 323–335, April 2, 2010 ª2010 Elsevier Inc. 329
Figure 5. Migration of hNPCs In Embryonic Mouse Brain Slices and the Adult Brain of a Mouse Stroke Model
(A) A diagram of the brain in the E14.5 forebrain slice culture.
(B) Scrambled LNA probe-transfected neurospheres derived from hESCs were transplanted into the medial ganglionic eminence (MGE).
(C) Transplanted hESC-derived neurospheres with miR-9 knockdown in the MGE. The arrowheads indicate a few migrating hNPCs.
Scale bars represent 50 mm.
(D) Maximum distance of hNPCmigration out of neurospheres. Values are the mean ± SEM of the five longest migrations. The quantification method is described
in Experimental Procedures. The numbers of transplanted neurospheres in one experiment are indicated in each column. This experiment was repeated twomore
times with similar results.
(E) Analysis of migration of transplanted hNPCs in the striatum toward areas of brain injury in a mouse model of stroke. hNPCs in different sampling areas (0–200,
201–400, 401–600, and >600 mm away from the transplanted hNPCs) were counted in each mouse after staining with anti-human mitochondria antibody (hMit).
(F) hNPCs transfected with scrambled LNA probe remained largely at the injection site.
(G) Some anti-miR-9-transfected hNPCs migrated away from the injection site toward the injury site. The arrowheads indicate a few migrating hNPCs.
Scale bars represent 200 mm.
(H) Percentages of migrated hNPCs in each area (n = 8 mice per group). Values are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.
See also Figures S5 and S6.
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pathways (Jin et al., 2004; Giampietro et al., 2005). Stathmin
also regulates cell proliferation and promotes the motility of
immortalized neuronal cells and human sarcoma cells (Giampie-
tro et al., 2005; Rubin and Atweh, 2004; Baldassarre et al., 2005).
Thus, it may be amolecular link betweenmiR-9 and hNPCmigra-
tion. Stathmin mRNA has a predicted miR-9 binding site in the
30UTR (Figure 6E), which is highly conserved from rodents to
humans (Figure 6F).
To further demonstrate a direct interaction between miR-9
and stathmin mRNA, we cotransfected HEK293 cells with pre-
miR-9-2 and a luciferase construct containing the 30UTR of
stathmin mRNA. We also generated a mutant 30UTR in which330 Cell Stem Cell 6, 323–335, April 2, 2010 ª2010 Elsevier Inc.three nucleotides in the seed region were altered to disrupt its
interaction with miR-9 (Figure 6E). In luciferase assays, miR-9
suppressed stathmin expression directly through its interaction
with the 30UTR (Figure 6G). The effect of miR-9 on the reporter
gene expression was lower than that on endogenous stathmin
mRNA, probably because expression of the reporter gene was
under the control of a strong promoter and transiently overex-
pressed. Thus, the molecular ratio of miR-target was different
in the two experiments.
Moreover, the miR-9-stathmin interaction was abolished by
transfecting a morpholino antisense oligonucleotide comple-
mentary to the 30UTR of stathmin. This target protector pre-
vented mir-9 binding and reduced stathmin expression in
Figure 6. Identification of Stathmin as a Key mRNA Target Directly Regulated by miR-9
(A) qRT-PCR analysis of expression profiles of miR-9 predicted mRNA targets during neuronal differentiation of hESCs. Expression was normalized to GADPH
mRNA levels. Values are mean ± SEM from at least three different cultures. See also Tables S1–S4.
(B) qRT-PCR analysis of mRNA expression levels of predicted targets of miR-9 in hNPCs 24 hr after transfection with anti-miR-9 and scrambled control probes.
Values are mean ± SEM from five experiments, normalized to levels in control-transfected hNPCs.
(C)Western blot analysis demonstrating the expression levels of stathmin, CHMP2B, and SIRT1 in hNPCs 24 hr after transfection with anti-miR-9. Actin served as
a loading control. This analysis was repeated three times. Values are the average fold changes in the expression levels of these proteins.
(D) Expression levels of predicted targets of miR-9 in HEK293 cells 48 hr after transfection with pre-miR-9-2. miR-124 precursor transfected HEK293 cells were
used as a negative control. Values are mean ± SEM.
(E) Sequence complementarity of a potential miR-9 binding site in the human stathmin 30UTR. The three nucleotides mutated for the luciferase assay control
experiment are underlined.
(F) Conserved nucleotides in human, rat, and mouse stathmin 30UTRs with complementarity to nucleotides 1–7, 9–11, and 12–15 of miR-9 (in gray).
(G) Relative luciferase activity of constructs containing the wild-type or mutant 30UTR of stathmin cotransfected into HEK293 cells in the presence of control or
pre-miR-9-2. Firefly luciferase activity was measured 48 hr after transfection and normalized to the cotransfected Renilla luciferase construct. WT-fl, wild-type
full-length stathmin 30UTR; WT-bs, wild-type partial stathmin 30UTR containing the putative miR-9 binding site; MUT-bs, partial stathmin 30UTR with mutated
seed region in the putative miR-9 binding site. For all panels, *p < 0.05, **p < 0.01, ***p < 0.001. Values are mean ± SEM.
See also Tables S1–S4.
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stathmin mRNA is a direct target of miR-9 in hNPCs.
Stathmin Mediates the Effects of miR-9 in Early hNPCs
During neural differentiation of hESCs, stathmin is markedly
downregulated only during the early neurosphere stage (16–
20 DIV) (Figure 6A). To determine whether the miR-9/stathmin
mRNA interaction modulates cellular behavior at this early stageof NPC maturation, we performed an epistasis experiment.
Transfection of stathmin siRNA in hNPCs reduced the mRNA
level by 76% (Figure S7A). The migration of the cells was not
altered, but the effect of miR-9 knockdown on stathmin expres-
sion was significantly suppressed (Figure S7A) and themigratory
phenotype of young hNPCs in the 3D Matrigel migration assay
was rescued (Figures 7A–7C). Moreover, loss of miR-9 activity
promoted migration of rat NPCs away from neurospheres in aCell Stem Cell 6, 323–335, April 2, 2010 ª2010 Elsevier Inc. 331
Figure 7. Stathmin Is an Essential Target of
miR-9 in Regulating NPC Migration and
Proliferation
(A and D) Scrambled LNA and control siRNA trans-
fected neurospheres.
(B and E) Anti-miR-9 LNA and control siRNA trans-
fected neurospheres.
(C and F) Anti-miR-9 LNA and stathmin siRNA
transfected neurospheres.
In (A)–(C), neurospheres derived from hESCs were
used, and images were obtained 4 days after
transfection and 1 day after embedding into the
3D Matrigel.
In (D)–(F), neurospheres derived from rat NPCs
were used; images were obtained 6 days after
transfection, and neurospheres were cultured on
the top of plastic substrates.
Scale bars represent 100 mm.
(G) Average distance between the nucleus of most
distal migrating hNPC from the neurosphere.
Values are mean ± SEM. n > 40 neurospheres.
Key in (K) also applies to (G)–(J).
(H) Number of rat NPCs that migrated away
from neurospheres. Values are mean ± SEM.
n > 40 neurospheres.
(I) Average distance from the neurosphere to the
nucleus of most distal migrating rat NPC. Values
are mean ± SEM. n > 40 neurospheres.
(J) Partial suppression of stathmin expression by
siRNA rescued the effect of loss of miR-9 activity
on the proliferation of hNPCs in the WST-1 assay.
Values are mean ± SEM.
(K) Maximum distances that hNPCs migrated out
of the neurospheres transplanted into the MGE.
Values are mean ± SEM. n > 15 neurospheres for
each conditions. The experiment was repeated
once with similar results.
In all panels, *p < 0.05, **p < 0.005, ***p < 0.001.
See also Figure S7.
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type, measured by the number of cells that migrated (Figure 7H)
and the distance traveled (Figures 7G and 7I), was suppressed
by simultaneous partial knockdown of stathmin. These findings
indicate that stathmin is a key downstream target whose upregu-
lation mediates the effect of loss of miR-9 on the migratory
behavior of hNPCs.
Partial inhibition of stathmin by siRNA blocked the effect of
loss of miR-9 on the proliferation of hNPCs in the WST-1 assay
(Figure 7J) and also increased the proliferation of rat cortical
NPCs in monolayer or in suspension cultures (Figures S7B and
S7C). More importantly, we used two different siRNA constructs
to partially inhibit stathmin expression in anti-miR-9 LNA-treated
hNPCs and then transplanted these cells into the medial gangli-332 Cell Stem Cell 6, 323–335, April 2, 2010 ª2010 Elsevier Inc.onic eminence of brain slices from E14.5
C57Bl/6 mouse embryos. The enhanced
migration of hNPCs in the absence of
miR-9 activity in this in vivo environment
was also suppressed by reduced stath-
min activity (Figure 7K). These findings
demonstrate that stathmin is a key target
essential for miR-9 to coordinate theproliferation and migration of hNPCs in vitro and in vivo
(Figure S7D).
DISCUSSION
Stem cell-based transplantation therapies for brain injuries and
degenerative diseases hold great promise but also face major
challenges, including the risk of uncontrolled proliferation and
tumor formation and the failure tomigrate to injured brain regions
and properly incorporate into the damaged neuronal circuitry.
Our findings here demonstrate an unexpected role for miR-9 in
coordinating the proliferation and migration of young hNPCs
derived from hESCs. Loss of miR-9 activity enhanced the migra-
tion of hNPCs transplanted into embryonic or adult mouse brains
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MicroRNA-9 in Human Neural Progenitorsin a stroke model. Because so little is known about the cellular
behavior of human neurons and their progenitor cells, our results
may help improve the clinical efficacy of cell therapies in the
nervous system via hESCs or iPSCs.
There are at least 400 miRNAs in humans and many of them
are not evolutionarily conserved, suggesting human-specific
functions. However, few have been studied with loss-of-function
approaches (Bartel, 2009). hESCs are an excellent model system
for studying the physiological functions and specific targets of
each endogenous human miRNA in different human cell types,
such as in neural progenitors during neuronal specification
from hESCs. To this end, the loss-of-function studies are criti-
cally important. Such approaches have been widely used in
other model organisms. For instance, genetic knockout of
miR-9 in Drosophila revealed an essential role in ensuring the
precision of SOP specification (Li et al., 2006). Morpholino
knockdown in zebrafish indicated a role for miR-9 in regulating
the organizing activity and neurogenesis at the midbrain-hind-
brain boundary (Leucht et al., 2008). Interestingly, although
miR-9 is 100% conserved at the sequence level, its expression
patterns and functions differ significantly in different organisms
(Delaloy and Gao, 2008). In neuronal differentiation of hESCs,
miR-9 expression is specifically turned on in hNPCs and main-
tained in postmitotic neurons. Our cell transplantation experi-
ments further demonstrate a novel cell-autonomous function
for miR-9 in regulating the migratory behavior of hNPCs.
Each miRNA may regulate hundreds of target mRNAs (Bartel,
2009). It is possible that many miRNAs exert their functions in a
specific biological process mainly through a few target mRNAs.
For instance, Senseless seems to be the key target in miR-9a
regulation of SOP specification in Drosophila (Li et al., 2006).
At themidbrain-hindbrain boundary in zebrafish, several compo-
nents of the FGF signaling pathway is targeted by miR-9 (Leucht
et al., 2008). In fly wing development, dLMO is another key target
of miR-9a (Biryukova et al., 2009). It was reported that miR-9
suppressed the expression of the transcription factor Foxg1
but not the nuclear receptor Tlx (also known as Nr2e1) during
Cajal-Retzius cell differentiation (Shibata et al., 2008). However,
another report suggested that overexpression of miR-9 sup-
pressed the expression of Tlx during the terminal differentiation
of adult mouse neural progenitor cells, resulting in increased
differentiation and migration of newborn neurons (Zhao et al.,
2009). The reasons for this discrepancy are unknown. In our
current study, stathmin seems to be a novel key target that is
essential for miR-9 to promote proliferation and limit migration
of multipotent hNPCs in the early neurosphere stage. Thus,
this specific miR-target interaction is essential to maintain the
hNPC pool at this particular stage. This conclusion, based on
extensive loss-of-function studies both in cell culture and in
transplantation experiments in mouse brains, does not exclude
the likely possibility that some other miR-9 targets are also
essential in this process.
There are several significant differences between the study
by Zhao et al. and ours. First, we used hESC-derived neural
progenitors instead of adult mouse neural progenitors. Second,
we performed our studies via loss-of-function approaches to
examine the physiologically relevant functions of endogenous
miR-9 in newly formed hNPCs. After miR-9 knockdown, hESC-
derived hNPCs maintained their neural progenitor propertiesand exhibited enhanced migration, both in vitro and after trans-
plantation into mouse embryonic or adult brains. In contrast,
Zhao et al. reported that migrating cells after miR-9 overexpres-
sion expressed neuronal but not progenitor markers, and they
failed to detect a change in cell differentiation in NPCs treated
with miR-9 antisense RNA. Third, the miR-9-Tlx mRNA interac-
tion was thought to be relevant only in adult neural progenitors
shortly before terminal differentiation was induced with retinoic
acid or forskolin (Zhao et al., 2009). In contrast, we studied newly
formedhNPCsbefore the expansion of theprogenitor pool. Thus,
the samemiRNAmayhavedistinct functions at different develop-
mental stages of various NPCs, probably by regulating different
spatially and temporally expressed mRNA targets (Figure S7D).
The molecular interaction between miR-9 and stathmin may
have important implications for other biological processes as
well. For instance, miR-9 is overexpressed in primary but not
metastatic brain tumors (Rosenfeld et al., 2008), and stathmin
enhances cancer cell migration and the metastatic phenotype
(Baldassarre et al., 2005; Belletti et al., 2008). Thus, manipulation
of the miR-9-stathmin interaction may suppress tumor formation
and enhance the migration of transplanted hNPCs and is there-
fore a potential target for improving the efficacy of stem cell-
based therapies.
EXPERIMENTAL PROCEDURES
Neural Differentiation of hESCs
Human ESCs (H9, passages 30–45; WiCell Research Institute) were cultured
on a layer of mouse embryonic fibroblasts (MEFs) (PMEF-CFL, Chemicon),
previously inactivated with mitomycin C (Roche), in DMEM/F12 medium sup-
plemented with 20% knockout serum replacement, 1 mM L-glutamine, 1%
nonessential amino acids, 4 ng/ml human FGF2 (Invitrogen), and 0.1 mM
2-mercaptoethanol (Chemicon). The medium was changed daily, and cells
were passaged every 4–6 days with 1 mg/ml collagen IV (Invitrogen). Neural
differentiation was induced as described with some modifications (Li and
Zhang, 2006; Zhang et al., 2001). Details can be found in Supplemental Infor-
mation. All the human stem cell work and experiments with animals were
approved by institutional committees.
Primary Culture of Rat Embryonic Cortical Neural Progenitor Cells
Rat embryonic cortical NPCs (R&D Systems) were cultured as a monolayer in
StemXVivo serum-free NSC Base medium, according to the manufacturer’s
protocol (R&D Systems) supplemented with 20 ng/ml human FGF2 (Invitrogen)
on plates coated with poly-L-ornithine and fibronectine (Sigma). Fresh FGF2
was added each day, and the medium was replaced every 2 days. Only
passages 1–3 were used for experiments. The neurosphere culture system
was used according to the manufacturer’s protocol (R&D Systems).
Analysis of miRNA and mRNA Expression
Total RNA was extracted and purified with the miRNeasy kit (Quiagen) and the
Turbo DNA free kit (Ambion). miRNA expression levels were quantified with
TaqMan microRNA assays (Applied Biosystems). Endogenous controls used
for real-time quantification are described in the Supplemental Information.
Real-time PCR analyses were performed in duplicate in 20 ml volumes for at
least three independent cultures. mRNA expression analysis is described in
the Supplemental Information.
Knockdown of miR-9 and STMN1
hNPCs at 16 DIV and rat cortical NPCs were transiently transfected with
miRCURY LNA knockdown probes (Exiqon) with Lipofectamine 2000 (Invitro-
gen) after additional mechanical dissociation into small clumps (10–50 cells).
A scrambled miRNA, 50-gtgtaacacgtctatacgccca, which bears no homology
to any known miRNA or mRNA sequences in human, mouse, and rat, was
used as negative control, and hsa-anti-miR-9 (100 nM) was used to specificallyCell Stem Cell 6, 323–335, April 2, 2010 ª2010 Elsevier Inc. 333
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siRNA (s8091 and s8093 at 20 nM; Ambion); Silencer Select Negative Control
1 siRNA (Ambion) was used as negative control.
30UTR Reporter Assays
The full-length (447 bp) 30UTR of the human stathmin gene and a fragment
(100 bp) containing the putative miR-9 binding site were amplified from human
genomic DNA and individually cloned into the pGl3-promoter vector (Promega).
A mutant construct with three base changes (CAA to GTT) in the seed region of
the miR-9 binding site was also generated. Pre-miR-9-2 was amplified from
a bacterial artificial chromosome containing the mouse genomic miR-9-2
sequence (bMQ-381K3;GeneService)andcloned into thepSUPERvectorunder
the control of the H1 promoter (OligoEngine). Transient transfection of HEK293
cells and gene reporter assays were carried out as described (Li et al., 2006).
In Situ Hybridization and Immunostaining
50-fluorescein-labeled miR-9 miRCURY detection probe (Exiqon) was used to
detect miR-9 expression in neurospheres. After immunostaining and fixation,
the cells were subjected to in situ hybridization as described (Politz et al.,
2006). For immunocytochemistry, cells were fixed with 4% paraformaldehyde
(PFA) for 10 min at room temperature and incubated with primary antibody
overnight at 4C. Staining with secondary antibodies was performed for 1 hr
at room temperature followed by Hoechst staining.
Cell Proliferation and Viability Assays
TUNEL Assay
The in situ cell death detection kit TMR Red (Roche) was used to label
apoptotic cells according to the manufacturer’s instructions. Neurospheres
were attached on Matrigel-coated flasks for a few hours before TUNEL assay
to allow better pictures of the cells.
Cytotoxicity Analysis
To assess the cytotoxicity of anti-miR-9 LNA, we measured LDH released into
culture medium upon cell lysis, with a nonradioactive cytotoxicity assay kit
(CytoTox 96, Promega). See Supplemental Information for details.
BrdU Staining
Neurospheres were attached on Matrigel-coated flasks for a few hours before
BrdU staining to allow better pictures of the cells. BrdU (10 mM) was added
to the culture medium for 4 hr. Cells were fixed in 4% paraformaldehyde
and stained with BrdU antibodies (Abcam) according the manufacturer’s
instructions. Cells were stained with Hoechst to quantify the proportion of
BrdU-positive cells in several random fields. More than 500 cells were counted
in each experiment, and the experiments were performed in triplicate.
WST1 Proliferation Assay
Proliferating cells were detected at various times with the WST1 cell-prolifera-
tion assay (Roche Applied Science) and cell proliferation was measured
according to the manufacturer’s instructions. hESC-derived neurospheres
were transfected with control or anti-miR-9 at 16 DIV. The next day, they
were seeded in 96-well plates (8 to 16 wells per conditions and time point).
The average absorbance at 450 nm for each time point was normalized to
the value on day 1 after transfection.
In Vitro Migration Assays
All migration experiments with rat cortical NPCs were performed in the
presence of FGF2 and epidermal growth factor on plastic substrates. One
day after transfection with Lipofectamine 2000, half of the medium was
replaced with fresh medium. Culture dishes were handled carefully to keep
the neurospheres at the bottom. Cell migration was evaluated by counting
cells that hadmigrated out from the neurospheres and measuring the distance
from the edge of the neurosphere to the nucleus of the most distant cell.
hNPCs were analyzed in a three-dimensional cell migration assay. Matrigel
(BD Biosciences) was diluted by half in neural induction medium, and 70 ml of
the mix was dispensed per well in a 96-well plate and allowed to polymerize at
37C overnight. Neurospheres (3 days after transfection) were placed onto the
polymerized Matrigel matrix and covered with 70 ml of Matrigel.
In Vivo Migration Assays
Neurospheres 150 mm in diameter were transplanted into the medial gangli-
onic eminence of coronal forebrain slices (see Supplemental Information for334 Cell Stem Cell 6, 323–335, April 2, 2010 ª2010 Elsevier Inc.details) with a glass pipette 150 mm in diameter to control for the size of the
neurospheres (Wichterle et al., 1999). The cocultures were maintained in
DMEM/F12 medium supplemented with 10% fetal calf serum and high
glucose. Four days after transplantation, hNPCs were visualized by fluores-
cence microscopy, and the distance between the migratory cells and the
edge of the transplanted neurospheres was measured. The migration of trans-
planted hNPCs in mouse brain slices was quantified in terms of the maximum
distance described in the Supplemental Information.
Permanent focal ischemia was induced in eight adult male CD-1 nude mice
(Charles River Laboratories) in each experiment by distal middle cerebral
artery occlusion. One week later, hNPCs transfected with scrambled or anti-
miR-9 LNA probes (1 3 104 cells/ml) were injected at a rate of 0.2 ml/min into
the striatum of each randomly picked mouse. Mice were sacrificed 48 hr later,
and 30-mm-thick frozen coronal brain sections were immunostained with the
anti-human mitochondria antibody (1:40, Chemicon). Most cells migrated
toward the injury site. We divided the migratory path into four sampling areas,
0–200, 200–400, 400–600 mm, and >600 mm away from the transplanted
hNPCs. With ImageJ software, we counted hMit-positive migrating cells and
determined the percentages of cells in each area. In each mouse, the average
from two to three coronal slices was obtained. Eight brains from two indepen-
dent experiments were analyzed for each condition.
Western Blotting
SDS-PAGE and western blotting were performed according to standard
procedures. b-Actin on the same membrane served as the loading control.
The primary antibodies used were anti-CHMP2B (Abcam AB33174), anti-
stathmin (Cell Signaling Technology), and anti-SIRT1 (gift of E. Verdin).
Densitometry analysis was carried out in Photoshop. The relative intensity is
the average of three different experiments.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and four tables and can be found with this article online at
doi:10.1016/j.stem.2010.02.015.
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